
Bioorganic & Medicinal Chemistry, Journal Year: 2024, Volume and Issue: unknown, P. 118054 - 118054
Published: Dec. 1, 2024
Language: Английский
Bioorganic & Medicinal Chemistry, Journal Year: 2024, Volume and Issue: unknown, P. 118054 - 118054
Published: Dec. 1, 2024
Language: Английский
Expert Opinion on Therapeutic Targets, Journal Year: 2023, Volume and Issue: 27(9), P. 763 - 778
Published: Sept. 2, 2023
Introduction Astrocytes have been previously considered as cells supporting neuronal functions, but they are now recognized active players in maintaining central nervous system (CNS) homeostasis. can communicate with other CNS i.e. through the gliotransmitter ATP and P2×7receptors (Rs).
Language: Английский
Citations
11Cells, Journal Year: 2024, Volume and Issue: 13(7), P. 571 - 571
Published: March 25, 2024
Extracellular vesicles (EVs) are secreted from many tumors, including glioblastoma multiforme (GBM), the most common and lethal brain tumor in adults, which shows high resistance to current therapies poor patient prognosis. Given relevance of information provided by cancer cell secretome, we performed a proteomic analysis microvesicles (MVs) exosomes (EXOs) released GBM-derived stem cells (GSCs). The latter, obtained GBM patients, expressed P2X7 receptors (P2X7Rs), positively correlate with growth invasiveness. P2X7R stimulation GSCs caused significant changes EV content, mostly ex novo inducing or upregulating expression proteins related cytoskeleton reorganization, motility/spreading, energy supply, protection against oxidative stress, chromatin remodeling, transcriptional regulation. Most induced/upregulated have already been identified as diagnostic/prognostic factors, while others only reported peripheral tumors. Our findings indicate that enhances transport and, therefore, possible intercellular exchange aggressiveness-increasing GSC-derived EVs. Thus, P2X7Rs could be considered new druggable target human GBM, although these data need confirmed larger experimental sets.
Language: Английский
Citations
4Current Opinion in Pharmacology, Journal Year: 2025, Volume and Issue: 80, P. 102503 - 102503
Published: Jan. 23, 2025
Language: Английский
Citations
0Biomedicine & Pharmacotherapy, Journal Year: 2025, Volume and Issue: 185, P. 117945 - 117945
Published: Feb. 27, 2025
Language: Английский
Citations
0Toxics, Journal Year: 2024, Volume and Issue: 12(3), P. 183 - 183
Published: Feb. 28, 2024
Efforts are being made globally to improve the evaluation and understanding of endocrine-disrupting chemicals. Recognition their impact on human health environment has stimulated attention research in this field. Various stakeholders, including scientists, regulatory agencies, policymakers, industry representatives, collaborating develop robust methodologies guidelines for assessing these disruptors. A key aspect efforts is development standardized testing protocols that aim provide consistent reliable methods identifying characterizing endocrine When evaluating potential activity chemicals, no single test capable detecting all relevant agents. The battery approach designed reduce risk false negative results compounds with toxic potential. weight-of-evidence therefore necessary disruptor evaluation. This considers various types data from multiple sources, overall strength, consistency, reliability evidence. OECD highly regarded scientific rigor, transparency, consensus-based process. It crucial explore new can effectively evaluate risks associated Integrating into a comprehensive framework will enhance assessments facilitate informed decisions regarding regulation management substances, ensuring protection adverse effects.
Language: Английский
Citations
2Expert Opinion on Therapeutic Patents, Journal Year: 2024, Volume and Issue: 34(4), P. 263 - 271
Published: April 2, 2024
Introduction The purinergic P2×7receptor is expressed on the surface of many different types cells, including immune cells. Targeting P2×7receptors with antagonists has been studied for its potential therapeutic effects in a variety inflammatory illnesses. It plays crucial role control responses.
Language: Английский
Citations
2Glia, Journal Year: 2023, Volume and Issue: 72(3), P. 475 - 503
Published: Nov. 1, 2023
Abstract Across the globe, approximately one in 10 babies are born preterm, that is, before 37 weeks of a typical 40 gestation. Up to 50% preterm infants develop brain injury, encephalopathy prematurity (EoP), substantially increases their risk for developing lifelong defects motor skills and domains learning, memory, emotional regulation, cognition. We still severely limited our abilities prevent or predict birth. No longer just “support cells,” we now clearly understand during development glia key building healthy brain. Glial dysfunction is hallmark EoP, notably, microgliosis, astrogliosis, oligodendrocyte injury. Our knowledge glial biology exponentially expanding but hasn't developed sufficiently effective neuroregenerative therapies. This review summarizes current state roles with EoP its animal models, description known glial‐cell interactions context such as border‐associated macrophages. The field perinatal medicine relatively small has worked passionately improve understanding etiology coupled detailed mechanistic studies pre‐clinical human cohorts. A primary finding from this collaborations computational biologists, working together complexity subtypes, maturation, impacts short long term will be design therapies outcomes.
Language: Английский
Citations
5Pharmaceutics, Journal Year: 2023, Volume and Issue: 15(9), P. 2263 - 2263
Published: Aug. 31, 2023
Graft-versus-host disease (GVHD) is a T cell-mediated inflammatory disorder that arises from allogeneic haematopoietic stem cell transplantation and often fatal. The P2X7 receptor an extracellular adenosine 5'-triphosphate-gated cation channel expressed on immune cells. Blockade of this with small molecule inhibitors impairs GVHD in humanised mouse model. A species-specific blocking monoclonal antibody (mAb) (clone L4) for human available, affording the opportunity to determine whether donor (human) contributes development mice. Using flow cytometric assays RPMI 8266 murine J774 cells, study confirmed mAb bound impaired P2X7. Furthermore, prevented loss regulatory cells (hTregs) natural killer (hNK) vitro. NOD-scid IL2Rγnull mice were injected 10 × 106 peripheral blood mononuclear (Day 0) anti-hP2X7 or control (100 μg i.p. per mouse, Days 0, 2, 4, 6, 8). increased hTregs hNK at Day 21. Moreover, mAb-treatment reduced clinical histological liver lung compared treatment endpoint. hTregs, hNK, proportions increased, helper 17 decreased These studies indicate blockade (donor) reduces mice, providing first direct evidence role GVHD.
Language: Английский
Citations
4The Ukrainian Biochemical Journal, Journal Year: 2024, Volume and Issue: 96(3), P. 5 - 12
Published: June 14, 2024
The review considers the effects of extracellular ATP mediated by plasma membrane purinoreceptors in cells different tissues, particular, myometrium. Recently published results suggest that cytosolic may also play a role signaling molecule, as indicated detection receptor not only membrane, but mitochondria. authors have shown ionized Ca2+ concentration rat myometrium mitochondria matrix is regulated at absence exogenous Ca2+. concentration-dependent increase [Ca2+]m was affected presence mitochondrial Ca2+-uniporter blocker ruthenium red, pore cyclosporine A, or synthase inhibitor oligomycin. It assumed could be molecule regulates least ions exchange Keywords: exchange, and ATP, mitochondria, P2X7 receptors
Language: Английский
Citations
1Purinergic Signalling, Journal Year: 2024, Volume and Issue: unknown
Published: July 20, 2024
Language: Английский
Citations
1